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*Providencia stuartii* is a frequent cause of urinary tract infections in hospital patients with long-term indwelling catheters ([@B1]). In these patients, bacteriuria may rapidly progress to bacteremia ([@B2], [@B3]). Infection with *P. stuartii* has also been reported to cause peritonitis ([@B4]), meningitis ([@B5]), pericarditis ([@B6]), and infective endocarditis ([@B7]). In an unusual case, *P. stuartii* was identified as the cause of a renal abscess mistakenly attributed to an infection with *Pasteurella* ([@B8]). Additionally, nosocomial dissemination of multidrug-resistant *P. stuartii* has been reported in burn units ([@B9], [@B10]) and an intensive care unit ([@B10]). Members of the genus *Providencia* harbor resistance to aminopenicillins and narrow-spectrum cephalosporins ([@B11]) but also readily acquire resistance to other antibiotics through horizontal transfer ([@B12], [@B13]). This is of great concern to public health due to the ability of *P. stuartii* to further disseminate antimicrobial resistance genes ([@B13], [@B14]). We present the complete genome of strain ATCC 33672, consisting of a 4.28-Mbp chromosome and a 48.9-kbp plasmid.

High-quality genomic DNA was extracted from a purified isolate using the Qiagen Genome-tip 500. Specifically, a 100-ml bacterial culture was grown to stationary phase and nucleic acid extracted as per the manufacturer's recommendations. The draft genome of *P. stuartii* ATCC 33672 included a combination of Illumina ([@B15]) and 454 technologies ([@B16]). For this genome, we constructed and sequenced a 100-bp Illumina library (372-fold genome coverage) and a long-insert paired-end 454 library (6,689 ± 1,140-bp insert; 5-fold genome coverage). Raw data are available in the Short Read Archive (SRA) under accession numbers SRX687103 (Illumina), SRX687104 (Illumina), and SRX687264 (454).

The 454 paired-end data were assembled in Newbler ([@B16]), and those consensus sequences were computationally shredded into 2-kbp overlapping fake reads (shreds). The Illumina sequencing data were assembled with Velvet ([@B17]), and the consensus sequences were computationally shredded into 1.5-kbp overlapping shreds. All data were additionally assembled in AllPaths ([@B18]), and the consensus sequences were computationally shredded into 5-kbp overlapping shreds. We integrated the 454 Newbler consensus shreds, the Illumina Velvet consensus shreds, AllPaths consensus shreds, and the 454 paired-end library read pairs using parallel Phrap (High Performance Software, LLC). Possible misassemblies were corrected and repeat regions verified using in-house scripts and manual editing in Consed ([@B19][@B20][@B21]).

The complete genome assembly of *P. stuartii* ATCC 33672, including a 4,285,951-bp circular chromosome (41.5% G+C content) and a 48,866-bp circular plasmid (42.8% G+C content), was annotated utilizing an Ergatis-based ([@B22]) workflow with minor manual curation. The annotated genome contains 4,094 predicted genes, including 3,926 protein-coding genes, 80 tRNA genes, and 22 rRNA genes. A total of 92 virulence genes were noted, including resistance to fluoroquinolones, β-lactams, and aminoglycosides.

Nucleotide sequence accession numbers. {#h1}
--------------------------------------

The nucleotide sequences for *P. stuartii* ATCC 33672 have been deposited in GenBank under accession numbers [CP008920](CP008920) (chromosome) and [CP008919](CP008919) (plasmid).
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